Skip to main content
Fig. 2 | BMC Rheumatology

Fig. 2

From: Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

Fig. 2

Distribution of simulation cohort over DAS-28 states, compared to observed distributions of RA patients in RIC I. Observed data is available at baseline (corresponds to baseline distribution for modelled patients), 6 months, 1 year, 3 years and at 5 years. DAS: DAS-28 state, Remission observed: percentage of observed patients in remission, low observed: percentage of observed patients in low DAS-28 state, moderate observed: percentage of observed patients in moderate DAS-28 state, high observed: percentage of observed patients in high DAS-28 state

Back to article page

BMC Rheumatology

ISSN: 2520-1026

Contact us